Workflow
柳药集团: 广西柳药集团股份有限公司关于以集中竞价交易方式回购股份的回购报告书

Core Viewpoint - The company plans to repurchase shares through a centralized bidding method, with a total repurchase amount ranging from RMB 100 million to RMB 200 million, aimed at implementing equity incentives and/or employee stock ownership plans in the future [1][3][11]. Summary by Relevant Sections Repurchase Plan Details - The repurchase amount will not be less than RMB 100 million and not exceed RMB 200 million [1][3]. - The funding sources for the repurchase will be the company's own funds and self-raised funds, with a loan commitment of up to RMB 180 million from a bank [1][10]. - The maximum repurchase price is set at RMB 25.70 per share, which is 150% of the average trading price over the previous 30 trading days [1][9]. Repurchase Execution - The repurchase will be conducted through a centralized bidding method and is expected to be completed within 12 months from the board's approval [2][5]. - The estimated number of shares to be repurchased ranges from approximately 389,110 shares to 778,210 shares, accounting for 0.98% to 1.96% of the total share capital [7][8]. Purpose and Impact - The repurchased shares will be used for equity incentives and/or employee stock ownership plans, enhancing investor confidence and aligning the interests of shareholders and employees [5][11]. - The company believes that the repurchase will not significantly impact its operations, financial status, or future development [11][12]. Shareholder Information - As of the board's approval date, major shareholders, including directors and actual controllers, have no plans to reduce their holdings in the next three to six months [2][13]. - The company has established a dedicated securities account for the repurchase, ensuring compliance with regulations [16].